ABBVIE INC. vs. Medicinova, Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ABBV | MNOV | |
|---|---|---|
| Market Cap | $466.55 billion | $88.11 million |
| Revenue (TTM) | $64.39 billion | $920,481 |
| Net Income (TTM) | $6.32 billion | $-10,753,049 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | MNOV | |
|---|---|---|
| P/E Ratio | 74.71 | — |
| Price / Book | -79.24 | 2.36 |
| Price / Sales | 7.25 | 95.72 |
ABBV leads on 2 of 2 valuation factors.
Profitability
| ABBV | MNOV | |
|---|---|---|
| Net Margin | 9.81% | -1168.20% |
| Return on Equity | -107.29% | -28.85% |
ABBV and MNOV split the profitability factors evenly.
Dividend
| ABBV | MNOV | |
|---|---|---|
| Dividend Yield | 2.62% | — |
| Payout Ratio | 195.48 | — |
ABBV and MNOV split the dividend factors evenly.
Risk & Sentiment
| ABBV | MNOV | |
|---|---|---|
| Short Interest | 0.85% | 4.32% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, MNOV overview, MNOV financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.